Skip to main content

PnuBioVax™: next-generation vaccine for a personalised and effective immune response against Streptococcus pneumoniae.

Project description

Next-generation vaccine against pneumococcal disease

Call for proposal

H2020-SMEInst-2018-2020-1
See other projects for this call

Coordinator

IMMUNOBIOLOGY LIMITED
Address
Babraham Research Campus Building 260
CB22 3AT Cambridge
United Kingdom
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 50 000